ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,322.42
      0.36%
      US Tech 100
      18,188.80
      0.66%
      Dow Jones
      40,050.45
      0.12%
      Brent Oil
      83.735
      0.17%
      Bitcoin
      66,904.56
      1.12%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. FibroBiologics Inc (FBLG)

      7. FibroBiologics Inc (FBLG) News

      FBLG

      FibroBiologics (FBLG)

      FibroBiologics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:FBLG
      DateTimeSourceHeadlineSymbolCompany
      05/15/20244:30PMGlobeNewswire Inc.FibroBiologics Announces 2024 Annual Meeting of StockholdersNASDAQ:FBLGFibroBiologics Inc
      05/15/20244:02PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FBLGFibroBiologics Inc
      05/14/20245:24PMGlobeNewswire Inc.FibroBiologics Files 2024 First Quarter ReportNASDAQ:FBLGFibroBiologics Inc
      05/14/20244:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBLGFibroBiologics Inc
      05/07/20249:31AMGlobeNewswire Inc.FibroBiologics to Present at the BIO International Convention 2024NASDAQ:FBLGFibroBiologics Inc
      04/25/20248:00AMGlobeNewswire Inc.FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based SpheroidsNASDAQ:FBLGFibroBiologics Inc
      04/11/20249:31AMGlobeNewswire Inc.FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent OfficeNASDAQ:FBLGFibroBiologics Inc
      04/04/20249:31AMGlobeNewswire Inc.FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USANASDAQ:FBLGFibroBiologics Inc
      03/28/20249:31AMGlobeNewswire Inc.FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of LupusNASDAQ:FBLGFibroBiologics Inc
      03/19/20249:31AMPR Newswire (US)FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes TreatmentNASDAQ:FBLGFibroBiologics Inc
      03/19/20249:31AMPR Newswire (US)FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes TreatmentNASDAQ:FBLGFibroBiologics Inc
      03/13/20249:31AMPR Newswire (US)FibroBiologics to Present at Advanced Wound Care Summit USANASDAQ:FBLGFibroBiologics Inc
      03/06/20249:31AMPR Newswire (US)FibroBiologics Appoints Ruben A. Garcia as General CounselNASDAQ:FBLGFibroBiologics Inc
      02/29/20245:44PMPR Newswire (US)FibroBiologics Files 2023 Form 10-K Annual ReportNASDAQ:FBLGFibroBiologics Inc
      02/20/20249:31AMPR Newswire (US)FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) ForumNASDAQ:FBLGFibroBiologics Inc
      02/13/20249:31AMPR Newswire (US)FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory DiseasesNASDAQ:FBLGFibroBiologics Inc
      02/08/20249:31AMPR Newswire (US)FibroBiologics Announces Three United States Patents for Fibroblast TechnologyNASDAQ:FBLGFibroBiologics Inc
      02/06/20249:31AMPR Newswire (US)FibroBiologics Announces Three Japanese Patents on Fibroblast TechnologyNASDAQ:FBLGFibroBiologics Inc
       Showing the most relevant articles for your search:NASDAQ:FBLG